Nextcure Stock Odds of Future Stock Price Finishing Over 1.6
| NXTC Stock | USD 0.83 0.04 4.60% |
NextCure |
NextCure Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NextCure for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NextCure can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NextCure generated a negative expected return over the last 90 days | |
| NextCure has some characteristics of a very speculative penny stock | |
| NextCure has high historical volatility and very poor performance | |
| NextCure has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (62.72 M) with loss before overhead, payroll, taxes, and interest of (54.2 M). | |
| NextCure currently holds about 185.49 M in cash with (52.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.68, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| NextCure has a frail financial position based on the latest SEC disclosures | |
| Roughly 58.0% of the company shares are owned by institutional investors |
NextCure Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NextCure Stock often depends not only on the future outlook of the current and potential NextCure's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NextCure's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 27.8 M | |
| Cash And Short Term Investments | 108.3 M |
NextCure Technical Analysis
NextCure's future price can be derived by breaking down and analyzing its technical indicators over time. NextCure Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NextCure. In general, you should focus on analyzing NextCure Stock price patterns and their correlations with different microeconomic environments and drivers.
NextCure Predictive Forecast Models
NextCure's time-series forecasting models is one of many NextCure's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary NextCure's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about NextCure
Checking the ongoing alerts about NextCure for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for NextCure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| NextCure generated a negative expected return over the last 90 days | |
| NextCure has some characteristics of a very speculative penny stock | |
| NextCure has high historical volatility and very poor performance | |
| NextCure has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (62.72 M) with loss before overhead, payroll, taxes, and interest of (54.2 M). | |
| NextCure currently holds about 185.49 M in cash with (52.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.68, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| NextCure has a frail financial position based on the latest SEC disclosures | |
| Roughly 58.0% of the company shares are owned by institutional investors |
Check out NextCure Backtesting, NextCure Valuation, NextCure Correlation, NextCure Hype Analysis, NextCure Volatility, NextCure History as well as NextCure Performance. For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NextCure. If investors know NextCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NextCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NextCure is measured differently than its book value, which is the value of NextCure that is recorded on the company's balance sheet. Investors also form their own opinion of NextCure's value that differs from its market value or its book value, called intrinsic value, which is NextCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NextCure's market value can be influenced by many factors that don't directly affect NextCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NextCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if NextCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NextCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.